BerganKDV Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

BerganKDV Wealth Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$67.3K	Buy	+1,000	New	+$61K	0.01%	347

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

BerganKDV Wealth Management's LMAT Position: Q2 2023 in Review

BerganKDV Wealth Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2023: 1,000 shares worth $67.3K. The stake represents 0.01% of the portfolio and ranks #347 among its holdings.

212 funds tracked by Wall St. Rank hold LMAT as of Q2 2023.

BerganKDV Wealth Management held 1,000 shares of LeMaitre Vascular worth $67.3K as of Q2 2023.
LeMaitre Vascular was a new BerganKDV Wealth Management position in Q2 2023.
LeMaitre Vascular made up 0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #347 holding.
212 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.